Oncotelic Therapeutics, Inc. Operating Lease, Expense
Oncotelic Therapeutics, Inc. (OTLC) reported Operating Lease, Expense of $35.77 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-05-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2020-05-14
- Oncotelic Therapeutics, Inc. operating lease, expense for the quarter ending 2019-12-31 was $0.00.
- Oncotelic Therapeutics, Inc. operating lease, expense for the quarter ending 2019-09-30 was $35.77K.
- Oncotelic Therapeutics, Inc. operating lease, expense for fiscal 2019 was $35.77K, a 0.00% change from fiscal 2018.
- Oncotelic Therapeutics, Inc. operating lease, expense for fiscal 2018 was $35.77K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-14 | $35.77K derived: sum of 2 quarters · filed 2020-05-14 | $35.77K 10-K · filed 2020-05-14 | |
| 2019-09-30 | $35.77K 10-Q · filed 2019-11-19 | $35.77K 10-Q · filed 2019-11-19 | ||
| 2018-12-31 | $35.77K 10-K · filed 2020-05-14 |